VHT
Price
$326.69Alerts
Change
-$1.30 (-0.40%)
Updated
Nov 20 closing price
Net Assets
20.64B
Intraday BUY SELL Signals
XLV
Price
$177.24Alerts
Change
-$0.22 (-0.12%)
Updated
Nov 20 closing price
Net Assets
47.91B
Intraday BUY SELL Signals
Interact to see
Advertisement

VHT vs XLV

VHT vs XLV Comparison Chart in %
loading
loading
View a ticker or compare two or three
A.I.Advisor
Nov 03, 2026

Which ETF would AI Choose? Vanguard Health Care ETF (VHT) vs. Health Care Select Sector SPDR Fund (XLV)

Key Takeaways

  • Same sector, different depth: VHT holds roughly 400+ health care stocks spanning large, mid, and small caps, while XLV holds about 60 large-cap names from the S&P 500.
  • Cost is nearly identical: VHT charges a 0.09% expense ratio versus 0.08% for XLV, making cost a minor factor in this ETF comparison.
  • Concentration differs materially: XLV's top 10 positions represent roughly 60% of assets, while VHT's top 10 account for a smaller share, reducing single-stock risk.
  • Risk profiles diverge: VHT's broader, deeper portfolio adds mid- and small-cap exposure, whereas XLV skews toward mega-cap, highly liquid leaders.
  • Tickeron AI Verdict: VHT edges out XLV on diversification breadth and reduced concentration risk with only a negligible cost disadvantage.

Introduction

Health care is one of the most durable and structurally defensive corners of the equity market, which makes direct comparisons between leading sector funds especially relevant during periods of economic uncertainty and shifting interest-rate expectations. VHT and XLV are two of the most widely held vehicles for U.S. health care exposure, and they compete directly for the same investor dollar. Both are passively managed, market-cap-weighted funds with near-identical top holdings, yet they deliver meaningfully different diversification profiles. Understanding their structural differences is essential for investors deciding which fund better matches their risk tolerance and return objectives.

Vanguard Health Care ETF (VHT) Overview

VHT seeks to track the MSCI US Investable Market Health Care 25/50 Index, a benchmark covering large, mid, and small U.S. companies classified within the health care sector under the Global Industry Classification Standard (GICS). With roughly 420 holdings, it provides one of the broadest pure-play health care exposures available. Its largest positions include LLY, JNJ, ABBV, MRK, and UNH, with additional weightings in TMO, AMGN, GILD, ABT, and PFE. The fund is passively managed using a replication and sampling approach, charges a 0.09% expense ratio, and launched in 2004. Its defining feature is depth: by reaching beyond the S&P 500, it captures smaller biotech, medical device, and health care services companies that large-cap-only funds exclude.

Health Care Select Sector SPDR Fund (XLV) Overview

XLV tracks the Health Care Select Sector Index, which includes health care companies drawn from the S&P 500. With roughly 60 to 65 holdings, it offers concentrated exposure to the sector's largest, most liquid names. Its top holdings mirror VHT's leadership — LLY, JNJ, ABBV, UNH, and MRK — followed by TMO, AMGN, GILD, ABT, and PFE. The fund is passively managed with a full replication strategy, charges a 0.08% expense ratio, and launched in 1998. Its concentration is notable: the top 10 holdings represent roughly 60% of assets, giving mega-cap pharmaceuticals and equipment makers outsized influence over performance and relative positioning.

Industry and Thematic Backdrop

Both funds operate within a health care sector shaped by several durable catalysts. Weight-loss and metabolic therapies have propelled a handful of large pharmaceutical leaders, while an aging U.S. population sustains structural demand for health care providers, insurers, and medical devices. Innovation in oncology and immunology continues to drive pipeline value, even as drug-pricing scrutiny and policy debate create periodic volatility. Interest-rate expectations matter as well: lower rates tend to support valuations of long-duration biotech and life sciences companies. Sector risks include regulatory changes, patent expirations, and reimbursement pressure, all of which can weigh on earnings cycles for top holdings across both portfolios.

Performance and Positioning Comparison

Because their top 10 holdings overlap heavily, VHT and XLV have historically moved in close tandem over recent market cycles, with differences driven primarily by concentration and small-cap exposure. XLV's heavier mega-cap weighting amplifies the influence of the largest pharmaceutical names, which can boost relative returns when mega-cap leadership is strong. VHT's inclusion of mid- and small-cap health care companies provides broader participation when smaller biotech and medical technology names rally, while also adding modest volatility. In recent weeks and months, both funds have reflected the same sector-level rotation, with relative positioning shaped more by concentration than by cost or tracking methodology.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics, making it easier to identify trade ideas, trending names, breakout candidates, and market opportunities more efficiently than manual screening. Whether you are comparing sector funds or hunting for emerging opportunities, the AI Screener can help you narrow the field with speed and precision.

Tickeron AI Verdict

Based on observable structural factors, Tickeron's AI would likely favor VHT over XLV at present. While XLV offers a marginally lower expense ratio and deeper liquidity, VHT's roughly 420-stock portfolio delivers substantially broader sector exposure and meaningfully lower single-stock concentration. For investors seeking diversified, all-cap health care access with comparable cost and trend consistency, VHT's wider net reduces idiosyncratic risk while still capturing the sector's dominant mega-cap leaders. The cost difference of one basis point is negligible, making VHT's diversification breadth the deciding factor in this comparison.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

VS
VHT vs. XLV commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VHT is a Hold and XLV is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for VHT with price predictions
Nov 20, 2026

VHT in -2.29% downward trend, declining for three consecutive days on November 20, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where VHT declined for three days, in 243 of 300 cases, the price declined further within the following month. The odds of a continued downward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for VHT moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 27 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 75%.

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VHT as a result. In 64 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.

The Moving Average Convergence Divergence Histogram (MACD) for VHT turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 34 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.

VHT moved below its 50-day moving average on November 20, 2026 date and that indicates a change from an upward trend to a downward trend.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for VHT crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.

Following a +0.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where VHT advanced for three days, in 254 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

VHT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 200 of 251 cases where VHT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.

A.I.Advisor
a Summary for XLV with price predictions
Nov 20, 2026

XLV in -2.17% downward trend, falling for three consecutive days on November 20, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where XLV declined for three days, in 250 of 308 cases, the price declined further within the following month. The odds of a continued downward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for XLV moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 27 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XLV as a result. In 72 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

The Moving Average Convergence Divergence Histogram (MACD) for XLV turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 38 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for XLV crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.

Following a +0.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in 264 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

XLV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 225 of 273 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.

TECHNICAL ANALYSIS
Technical Analysis
VHTXLV
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
73%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement

XLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, XLV has been closely correlated with LLY. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLV jumps, then LLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLV
1D Price
Change %
XLV100%
-0.12%
LLY - XLV
76%
Closely correlated
-0.30%
MRK - XLV
67%
Closely correlated
+0.69%
JNJ - XLV
66%
Loosely correlated
+1.25%
ABBV - XLV
65%
Loosely correlated
+0.94%
BMY - XLV
63%
Loosely correlated
+0.79%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NXUS24.480.10
+0.39%
NuShares ETF Trust Nuveen International Aggregate Bond ETF (NXUS)
FDRS23.94N/A
N/A
Founder-Led ETF
BUCK23.06-0.04
-0.17%
Simplify Treasury Option Income ETF (BUCK)
DSMC42.31-0.63
-1.46%
Distillate Small/Mid Cash Flow ETF (DSMC)
RBLD78.83-2.36
-2.91%
First Trust Alerian US NextGen Infrastructure ETF (RBLD)
Interesting Articles